Clinical Pharmacology of CHF 1535 50/6 ug Next DPI in Children 5-11 Years Old
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This is a pharmacokinetic comparison of CHF 1535 50/6 NEXT DPI versus the free combination of
Beclomethasone DPI and Formoterol DPI in children (5 to 11 years old) of a formulation
already approved in adults.